Carbidopa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Oceanside Pharmaceuticals. The primary component is Carbidopa.
Product ID | 68682-200_32765836-72d3-4eb4-9f96-589f9518d3be |
NDC | 68682-200 |
Product Type | Human Prescription Drug |
Proprietary Name | Carbidopa |
Generic Name | Carbidopa Tablets |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2014-04-04 |
Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
Application Number | NDA017830 |
Labeler Name | Oceanside Pharmaceuticals |
Substance Name | CARBIDOPA |
Active Ingredient Strength | 25 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-04-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA authorized generic |
Application Number | NDA017830 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-04-04 |
Ingredient | Strength |
---|---|
CARBIDOPA | 25 mg/1 |
SPL SET ID: | d5204e5e-10ef-4758-8fc6-cb710048c687 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
16714-067 | Carbidopa | Carbidopa |
40032-980 | Carbidopa | Carbidopa |
42799-123 | Carbidopa | Carbidopa |
43386-980 | Carbidopa | Carbidopa |
43975-220 | Carbidopa | Carbidopa |
51407-314 | Carbidopa | Carbidopa |
59651-146 | Carbidopa | Carbidopa |
63629-1932 | Carbidopa | Carbidopa |
63629-9193 | Carbidopa | Carbidopa |
68682-200 | Carbidopa | Carbidopa Tablets |
70710-1221 | CARBIDOPA | CARBIDOPA |
70771-1355 | CARBIDOPA | CARBIDOPA |
25010-711 | Lodosyn | carbidopa |